Hartoun Hartounian

Calculated based on number of publications stored in Pure and citations from Scopus
1988 …2019

Research activity per year

Network

M. Patel

  • SkyePharma Inc.
  • Rutgers - The State University of New Jersey, New Brunswick
  • Sequenom, Inc.
  • Instrumentation Society of America
  • Sequenom Inc.
  • Rutgers University

External person

C. Pepper

  • SkyePharma Inc.
  • Washington State University Pullman
  • University of California at Los Angeles
  • DepoTech Corporation
  • ISPE
  • Proc. Development and Manufacturing
  • Amer. Inst. of Chemical Engineers

External person

S. I. Sandler

  • University of Delaware
  • Department of Chemical Engineering
  • University of Delaware College of Engineering

External person

E. W. Kaler

  • University of Delaware
  • Department of Chemical Engineering

External person

David T. Allen

  • University of California at Los Angeles
  • Department of Chemical Engineering

External person

Jeremy M. Levin

  • Ovid Therapeutics

External person

Gerald F. Cox

  • Harvard University
  • Gerald Cox Rare Care Consulting
  • Boston Children's Hospital

External person

Gustav Christensen

  • Morphic Therapeutic
  • Morphic Therapeutic

External person

Ronald A. DePinho

  • University of Texas MD Anderson Cancer Center

External person

Gregory J. Flesher

  • Novus Therapeutics, Inc.

External person

David Bartel

  • Whitehead Institute for Biomedical Research
  • Howard Hughes Medical Institute

External person

Peter Barrett

  • Atlas Venture
  • Atlas Venture

External person

Jean Francois Formela

  • Atlas Venture
  • Atlas Venture

External person

Joshua Boger

  • Vertex Pharmaceuticals, Inc.

External person

Jim Bollenbacher

  • Bridgeway Search Group

External person

L. Patrick Gage

  • enGage Biotech Consulting

External person

Sally J. Curley

  • Curley Global IR (CGIR), LLC

External person

Douglas Doerfler

  • MaxCyte, Inc

External person

Cedric Francois

  • Apellis Pharmaceuticals

External person

Bruce Booth

  • Atlas Venture
  • Atlas Venture

External person

Ron Cohen

  • Acorda Therapeutics, Inc

External person

Jason Gardner

  • Magenta Therapeutics

External person

Deborah Dunsire

  • H. Lundbeck A/S

External person

Pavan Cheruvu

  • Axovant Sciences

External person

Michael P. Franken

  • TEQLA Therapeutics Inc.

External person

James E. Audia

  • Northwestern University

External person

Steven H. Holtzman

  • Decibel Therapeutics
  • Decibel Therapeutics, Inc.

External person

Wayne Eskridge

  • Fatty Liver Foundation

External person

Kenneth Fong

  • System Biosciences, Inc.

External person

John Diekman

  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures

External person

Henry E. Chang

  • Hepatitis Business Solutions, LLC

External person

J. A. Koetitz

  • University of Delaware
  • Department of Chemical Engineering

External person

Jeff Albers

  • Blueprint Medicines
  • Blueprint Medical Corporation

External person

Yang Xin Fu

  • University of Texas Southwestern Medical Center

External person

Daniel Dornbusch

  • Excision BioTherapeutics

External person

J. Ricci

  • DepoTech Corporation

External person

Richard H. Ebright

  • Rutgers - The State University of New Jersey, New Brunswick

External person

Charles L. Cooney

  • Massachusetts Institute of Technology

External person

Anne E. Carpenter

  • Broad Institute

External person

Heather Franklin

  • Blaze Bioscience, Inc.

External person

Richard H. Douglas

  • Aldeyra Therapeutics

External person

Michael P. Bailey

  • AVEO Oncology

External person

Phyllis Gardner

  • Stanford University

External person

Joseph E. Aoun

  • Northeastern University

External person

Olivier Brandicourt

  • Sanofi-Aventis

External person

E. Floeter

  • University of Delaware
  • Department of Chemical Engineering

External person

Kaye Foster-Cheek

  • Agios Pharmaceuticals

External person

George Church

  • Harvard University

External person

Mohamed Genead

  • AVICEDA Therapeutics LLC

External person

Robert I. Blum

  • Cytokenetics, Inc.

External person

D. Meissner

  • DepoTech Corporation

External person

Michael D. Clayman

  • Flexion Therapeutics, Inc.
  • Flexion Therapeutics Inc.

External person

Michael W. Bonney

  • Magenta Therapeutics
  • Kaleido Biosciences Inc.

External person

Jean Jacques Bienamie

  • BioMarin Pharmaceutical Inc.

External person

Eugene Braunwald

  • Harvard University

External person

John Maraganore

  • Alnylam Pharmaceuticals

External person